This latter pathway is up-regulated in FH mutant tumor cells and inhibition of heme oxygenase specifically killed FH mutant tumor cells suggesting a novel therapeutic approach to treating cancers with FH mutation (251). This evidence concerns the gene FH and neoplasm.